Mihelich_Brittany.pdf (6.81 MB)
0/0

MicroRNAs as Zinc Regulators in Cancer Cells and as Serum Markers of Aggressive Prostate Cancer

Download (6.81 MB)
thesis
posted on 28.10.2014 by Brittany Mihelich
This work examines the role of specific miRNAs in the molecular etiology of prostate cancer, their secretion from cells, and their application to blood-based biomarkers of aggressive prostate cancer. In Chapter II, we identified the miR-183 cluster in the regulation of zinc homeostasis in prostate cells. Zinc is normally accumulated to high levels in prostate tissue, yet is lost in prostate cancer. The miR-183 cluster was overexpressed in prostate cancer tissue and targets zinc transporters, reducing the cellular import and concentration of zinc. The secretion of the miR-183 cluster in cellular exosomes was investigated in Chapter III. Of the members of the miR-183 cluster, only miR-182 was secreted in exosomes from prostate and breast cancer cell lines. When miR-182 was overexpressed in breast cancer cells, it was packaged into exosomes at a higher level. Furthermore, these exosomes reduced zinc in recipient cells. In Chapter IV, we examined circulating miRNAs as potential prognostic biomarkers for prostate cancer. A signature of fourteen miRNAs was discovered that identified a subset of patients that have indolent, non-aggressive disease. Furthermore, eight of these miRNAs also identified patients that do not have biochemical recurrence after prostatectomy. We took a translational approach with this work, from discovering the miRNA-mediated basis of zinc loss to the application of miRNAs to a clinical need.

History

Advisor

Diamond, Alan

Department

Pathology

Degree Grantor

University of Illinois at Chicago

Degree Level

Doctoral

Committee Member

Nonn, Larisa Kajdacsy-Balla, Andre Kittles, Rick Paroo, Zain

Submitted date

2014-08

Language

en

Issue date

28/10/2014

Exports

Categories

Exports